Education
About Us
Working with TipRanks
Follow Us
Jeffrey Kindler Insider Profile
4 Followers
Jeffrey Kindler, Director at vTv Therapeutics, holds 346.07K shares in Precigen (Ticker: PGEN), holds 10.56K shares in Perrigo Company (Ticker: PRGO), holds 0.00 shares in PPD (Ticker: PPD). Most recently, Jeffrey Kindler Sold ― shares of Precigen on Oct 01, 2025 for an estimated value of $604.19K.
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+20.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey Kindler holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeffrey Kindler
Jeffrey Kindler's Trading History
vTv Therapeutics
Mar 11, 2020
Director
Uninformative Buy
31.50K
$843.50K
Perrigo Company
May 16, 2025
Director
Uninformative Buy
133.95K
$237.68K
PPD
Dec 08, 2021
―
Uninformative Sell
5.60M
$0.00
Terns Pharmaceuticals
―
Director
―
―
Precigen
Oct 01, 2025
Director
Informative Sell
604.19K
$1.12M
Pfizer
May 27, 2010
Former Chairman & CEO, Director
Uninformative Sell
―
$22.91M
Chipotle
May 16, 2014
Director
Uninformative Buy
―
$64.94K
SIGA Technologies
May 22, 2020
Director
Uninformative Buy
89.85K
$1.14M
List of latest transactions for each holding click on a transaction to see Jeffrey Kindler's performance on stock
You May Also Like
Jeffrey Kindler insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Kindler?
The percentage of profitable transactions made by Jeffrey Kindler is 83%.
What is the average return per transaction made by Jeffrey Kindler?
The average return per transaction made by Jeffrey Kindler is 20.90%.
What stocks does Jeffrey Kindler hold?
Jeffrey Kindler holds: VTVT, PRGO, PPD, TERN, PGEN, PFE, CMG, SIGA stocks.
What was Jeffrey Kindler’s latest transaction?
Jeffrey Kindler latest transaction was an Informative Sell of $604.19K.
What was Jeffrey Kindler's most profitable transaction?
Jeffrey Kindler’s most profitable transaction was an Informative Sell of PGEN stock on December 29, 2023. The return on the trade was 45.80%.
What is Jeffrey Kindler's role in vTv Therapeutics?
Jeffrey Kindler's role in vTv Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.